Lauren Santye, Assistant Editor

Research identifies important therapeutic target in cancer treatment.

New system that can produce different drugs offers hope for orphan diseases.

Vismodegib and sonidegib reduced advanced basal cell carcinoma tumors in 43% of patients with locally advanced disease.

Natalizumab has been generally considered among the most effective treatments for relapsing-remitting multiple sclerosis.

Vismodegib and sonidegib reduced advanced basal cell carcinoma tumors in 43% of patients with locally advanced disease.

Compounds derived from a drug previously investigated for the treatment of Ewing sarcoma.

Women with proliferating cells within mammary epithelium cells significantly more likely to develop breast cancer.

Incretin-based drugs help type 2 diabetes patients reduce blood sugar.

Incretin-based drugs help type 2 diabetes patients reduce blood sugar.

African Americans and Hispanics reported healthcare experiences as being similar to or worse than those experienced by Whites.

Radiation therapy plus chemotherapy extends overall survival in patients with grade 2 glioma.

Radiation therapy plus chemotherapy extends overall survival in patients with grade 2 glioma.

Increased amount of specific fatty acid underlies type 1 diabetes and obesity-related kidney dysfunction.

Combination treatment approach helps control diabetes and obesity.

Combination treatment approach helps control diabetes and obesity.

Targeted approach may lead to improved treatments for cancer.

Prognostic model provides simple and accurate clinical description for each HCC patient.

Top news of the day from across the health care landscape.

Cortistatin A is a natural product isolated from an Indonesian marine sponge with potent anti-angiogenic activity at low dosages.

Adherence to antiretroviral treatment negatively affected among patients with HIV who use drugs.

Top news of the day from across the health care landscape.

Chinese plant Huang-Qin compound shows promise treating cancer and liver disease.

CTLA-4 molecule on T cells offer potential therapeutic target.

Study reports the second known real world data set for HCV patients coinfected with HIV treated with Sovaldi or Harvoni.

High prevalence of anti-HIV antibodies found in patients with hepatitis C and hepatitis B.

Faulty protein kinases can lead to conditions such as diabetes, cancer, and cardiovascular disease.

The right combination of direct acting antiviral drugs is vital for patients with HCV.

Top news from across the health care landscape.

Patients with HCV genotype 3 without scarred livers achieved SVR after 8 weeks.

Patients with HCV genotype 3 without scarred livers achieved SVR after 8 weeks.